Jorey Chernett, Owner of More than 5.5% of Outstanding Shares of CVRx, Calls on Board to Begin Immediate Process to Pursue Sale of the Company to a Strategic AcquirerPRNewsWire • 08/24/26
CVRx Announces Devoted Health Medicare Advantage Coverage Policy for Barostim TherapyGlobeNewsWire • 08/24/26
CVRx, Inc. Investigated For Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the FirmNewsfile Corp • 08/18/26
CVRX ALERT: Securities Fraud Investigation by Block & Leviton Could Allow CVRx, Inc. Investors to Recover LossesNewsfile Corp • 08/13/26
Securities Fraud Investigation Into CVRx, Inc. (CVRX) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. CruzBusiness Wire • 08/11/26
CVRx, Inc. (CVRX) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud InvestigationBusiness Wire • 08/11/26
Securities Fraud Investigation Into CVRx, Inc. (CVRX) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law FirmBusiness Wire • 08/10/26
CVRX INVESTIGATION: CVRx, Inc. Investigated for Securities Fraud by Block & Leviton; Investors Should Contact the Firm to Possibly Recover LossesGlobeNewsWire • 08/10/26
CVRx, Inc. (CVRX) Investors Who Suffered Losses Are Encouraged to Contact Johnson Fistel Following Revenue Guidance Cut and Sales-Execution DisclosuresGlobeNewsWire • 08/07/26
Compared to Estimates, CVRx (CVRX) Q2 Earnings: A Look at Key MetricsZacks Investment Research • 08/07/26
CVRx to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call on August 6, 2026GlobeNewsWire • 07/23/26
CVRx, Inc. (CVRX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptSeeking Alpha • 06/10/26
CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare ConferenceGlobeNewsWire • 05/27/26